Pulmatrix (PULM)
(Delayed Data from NSDQ)
$2.13 USD
+0.04 (1.92%)
Updated Oct 16, 2024 03:59 PM ET
After-Market: $2.13 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Pulmatrix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7 | 6 | 5 | 13 | 8 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 7 | 6 | 5 | 13 | 8 |
Selling & Adminstrative & Depr. & Amort Expenses | 22 | 25 | 25 | 23 | 29 |
Income After Depreciation & Amortization | -15 | -19 | -20 | -10 | -21 |
Non-Operating Income | 1 | 0 | 0 | -9 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -14 | -19 | -20 | -19 | -21 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | -19 | -20 | -19 | -21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | -19 | -20 | -19 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -13 | -17 | -15 | -9 | -13 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 5 | 1 | 8 |
Income After Depreciation & Amortization | -15 | -19 | -20 | -10 | -21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3.65 | 3.45 | 2.71 | 1.44 | 0.84 |
Diluted EPS Before Non-Recurring Items | -3.87 | -5.46 | -7.31 | -13.40 | -16.00 |
Diluted Net EPS (GAAP) | -3.87 | -5.46 | -8.63 | -13.40 | -24.60 |
Fiscal Year end for Pulmatrix, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 1.55 | 5.89 | 2.20 | 1.75 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 1.55 | 5.89 | 2.20 | 1.75 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 7.45 | 5.14 | 4.43 | 5.69 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.90 | 0.75 | -2.23 | -3.94 |
Non-Operating Income | NA | 0.09 | 0.08 | 0.14 | 0.17 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -5.81 | 0.83 | -2.08 | -3.77 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.81 | 0.83 | -2.08 | -3.77 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.81 | 0.83 | -2.08 | -3.77 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 3.65 | 3.65 | 3.65 | 3.65 |
Diluted EPS Before Non-Recurring Items | NA | -0.87 | 0.23 | -0.57 | -1.03 |
Diluted Net EPS (GAAP) | NA | -1.59 | 0.23 | -0.58 | -1.03 |